Analytical strategies for assessing comp
β
Robert J. Falconer; Dianne Jackson-Matthews; Stephen M. Mahler
π
Article
π
2011
π
Wiley (John Wiley & Sons)
π
English
β 122 KB
## Abstract Biosimilar products are required by regulatory authorities to have appropriate and comparable quality, safety and efficacy with a reference biologic product. The analytical techniques that are available to manufacturers of biosimilar medicines are well advanced and present a range of op